Literature DB >> 17097770

Voxel-based morphometry in autopsy proven PSP and CBD.

Keith A Josephs1, Jennifer L Whitwell, Dennis W Dickson, Bradley F Boeve, David S Knopman, Ronald C Petersen, Joseph E Parisi, Clifford R Jack.   

Abstract

The aim of this study was to compare the patterns of grey and white matter atrophy on MRI in autopsy confirmed progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD), and to determine whether the patterns vary depending on the clinical syndrome. Voxel-based morphometry was used to compare patterns of atrophy in 13 PSP and 11 CBD subjects and 24 controls. PSP and CBD subjects were also subdivided into those with a dominant dementia or extrapyramidal syndrome. PSP subjects showed brainstem atrophy with involvement of the cortex and underlying white matter. Frontoparietal grey and subcortical grey matter atrophy occurred in CBD. When subdivided, PSP subjects with an extrapyramidal syndrome had more brainstem atrophy and less cortical atrophy than CBD subjects with an extrapyramidal syndrome. PSP subjects with a dementia syndrome had more subcortical white matter atrophy than CBD subjects with a dementia syndrome. These results show regional differences between PSP and CBD that are useful in predicting the underlying pathology, and help to shed light on the in vivo distribution of regional atrophy in PSP and CBD.

Entities:  

Mesh:

Year:  2006        PMID: 17097770      PMCID: PMC2702857          DOI: 10.1016/j.neurobiolaging.2006.09.019

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  56 in total

1.  Thresholding of statistical maps in functional neuroimaging using the false discovery rate.

Authors:  Christopher R Genovese; Nicole A Lazar; Thomas Nichols
Journal:  Neuroimage       Date:  2002-04       Impact factor: 6.556

2.  Progressive supranuclear palsy with dementia: cortical pathology.

Authors:  E H Bigio; D F Brown; C L White
Journal:  J Neuropathol Exp Neurol       Date:  1999-04       Impact factor: 3.685

3.  Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.

Authors:  D W Dickson; C Bergeron; S S Chin; C Duyckaerts; D Horoupian; K Ikeda; K Jellinger; P L Lantos; C F Lippa; S S Mirra; M Tabaton; J P Vonsattel; K Wakabayashi; I Litvan
Journal:  J Neuropathol Exp Neurol       Date:  2002-11       Impact factor: 3.685

4.  Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.

Authors:  F Yekhlef; G Ballan; F Macia; O Delmer; C Sourgen; F Tison
Journal:  J Neural Transm (Vienna)       Date:  2003-02       Impact factor: 3.575

5.  Atrophy of superior cerebellar peduncle in progressive supranuclear palsy.

Authors:  Y Tsuboi; J Slowinski; K A Josephs; W G Honer; Z K Wszolek; D W Dickson
Journal:  Neurology       Date:  2003-06-10       Impact factor: 9.910

Review 6.  Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia.

Authors:  Bradley F Boeve; Anthony E Lang; Irene Litvan
Journal:  Ann Neurol       Date:  2003       Impact factor: 10.422

7.  Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy.

Authors:  C Brenneis; K Seppi; M Schocke; T Benke; G K Wenning; W Poewe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

8.  Pathologically confirmed corticobasal degeneration presenting with visuospatial dysfunction.

Authors:  D F Tang-Wai; K A Josephs; B F Boeve; D W Dickson; J E Parisi; R C Petersen
Journal:  Neurology       Date:  2003-10-28       Impact factor: 9.910

9.  Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.

Authors:  Klaus Gröschel; Till-Karsten Hauser; Andreas Luft; Nicholas Patronas; Johannes Dichgans; Irene Litvan; Jörg B Schulz
Journal:  Neuroimage       Date:  2004-02       Impact factor: 6.556

10.  Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias.

Authors:  Catriona D Good; Rachael I Scahill; Nick C Fox; John Ashburner; Karl J Friston; Dennis Chan; William R Crum; Martin N Rossor; Richard S J Frackowiak
Journal:  Neuroimage       Date:  2002-09       Impact factor: 6.556

View more
  102 in total

1.  Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials.

Authors:  Jennifer L Whitwell; Jia Xu; Jay N Mandrekar; Jeffrey L Gunter; Clifford R Jack; Keith A Josephs
Journal:  Parkinsonism Relat Disord       Date:  2011-11-13       Impact factor: 4.891

2.  Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome.

Authors:  Naomi Kouri; Melissa E Murray; Anhar Hassan; Rosa Rademakers; Ryan J Uitti; Bradley F Boeve; Neill R Graff-Radford; Zbigniew K Wszolek; Irene Litvan; Keith A Josephs; Dennis W Dickson
Journal:  Brain       Date:  2011-09-20       Impact factor: 13.501

3.  Caudate atrophy on MRI is a characteristic feature of FTLD-FUS.

Authors:  K A Josephs; J L Whitwell; J E Parisi; R C Petersen; B F Boeve; C R Jack; D W Dickson
Journal:  Eur J Neurol       Date:  2010-03-03       Impact factor: 6.089

4.  Impaired information integration contributes to communication difficulty in corticobasal syndrome.

Authors:  Rachel G Gross; Sharon Ash; Corey T McMillan; Delani Gunawardena; Chivon Powers; David J Libon; Peachie Moore; Tsao-Wei Liang; Murray Grossman
Journal:  Cogn Behav Neurol       Date:  2010-03       Impact factor: 1.600

5.  The relationship between clinical and pathological variables in Richardson's syndrome.

Authors:  Emma C Schofield; John R Hodges; Thomas H Bak; John H Xuereb; Glenda M Halliday
Journal:  J Neurol       Date:  2011-08-12       Impact factor: 4.849

6.  Magnetic resonance imaging in progressive supranuclear palsy.

Authors:  M Stamelou; S Knake; W H Oertel; G U Höglinger
Journal:  J Neurol       Date:  2010-12-22       Impact factor: 4.849

Review 7.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

8.  MRI correlates of protein deposition and disease severity in postmortem frontotemporal lobar degeneration.

Authors:  Jennifer L Whitwell; Clifford R Jack; Matthew L Senjem; Joseph E Parisi; Bradley F Boeve; David S Knopman; Dennis W Dickson; Ronald C Petersen; Keith A Josephs
Journal:  Neurodegener Dis       Date:  2009-03-19       Impact factor: 2.977

9.  Symmetric corticobasal degeneration (S-CBD).

Authors:  Anhar Hassan; Jennifer L Whitwell; Bradley F Boeve; Clifford R Jack; Joseph E Parisi; Dennis W Dickson; Keith A Josephs
Journal:  Parkinsonism Relat Disord       Date:  2009-12-16       Impact factor: 4.891

Review 10.  Neurodegenerative dementia and parkinsonism.

Authors:  A Gabelle; F Portet; C Berr; J Touchon
Journal:  J Nutr Health Aging       Date:  2010-01       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.